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Abstract: Cancer is one of the most prevalent diseases in the world and requires new therapies for 
its treatment. In this context, the biosynthesis of silver nanoparticles (AgNPs) has been developed 
to treat different types of tumors. The Annona muricata plant is known for having anticancer activity. 
Its main compounds present in the leaves, stems and skin, allowing for its use as reducing agents. 
In this manuscript, AgNPs with leaf extract (AgNPs-LE) and fruit peel extract (AgNPs-PE) of A. 
muricata were biosynthesized obtaining an average nanoparticle diameter sizes smaller than 50 nm, 
being 19.63 ± 3.7 nm and 16.56 ± 4.1 nm, and with a surface plasmonic resonance (SPR) at 447 and 
448 nm, respectively. The lactone functional group present in the LE and PE extracts was identified 
by the FTIR technique. The behavior and antiproliferation activity of AgNPs-LE and AgNPs-PE 
were evaluated in breast, colon and melanoma cancer cell lines. Our results showed that Annona 
muricata fruit peel, which is a waste product, has an antitumor effect more potent than leaf extract. 
This difference is maintained with AgNPs where the destruction of cancer cells was, for the first 
time, achieved using concentrations that do not exceed 3 μg/mL with a better therapeutic index in 
the different tumor strains. In conclusion, we present a low-cost one-step experimental setup to 
generate AgNPs-PE whose in-vitro biocompatibility and powerful therapeutic effect make it a very 
attractive tool worth exploiting. 
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Cancer is considered a worldwide public health problem [1]. The International 
Agency for Research on Cancer estimated that in the years 2018 and 2020, 18.1 and 19.3 
million cancers were diagnosed across the world. However, the COVID-19 pandemic has 
most probably affected the number of cancer diagnoses in many countries, so the actual 
number of cancers diagnosed in 2020 will likely have been lower. Global estimates also 
indicate that the number of new cases will increase over the next two decades to 30.2 mil-
lion new cases per year by 2040. Currently, colon cancer, breast cancer and melanoma are 
among the cancers with the highest incidence and mortality rates [2]. Conventional treat-
ments such as chemotherapy, radiotherapy, surgery and hormone therapy have certain 
limitations [3], and research for new and more efficient therapies is required. 
Nowadays, a number of innovative cancer treatments are underway and mostly are 
in preclinical trials, with challenges remaining in administration, effectiveness and safety. 
Nanotechnology has led to advanced approaches in the screening, diagnosis, and treat-
ment of cancer [4]. Synthesis of noble metal nanoparticles such as gold, copper and silver 
for applications in the medical area is of constant interest. In this context, silver nanopar-
ticles (AgNPs) are attractive due to their exclusive optical, electrical, magnetic and thermal 
properties which can be incorporated into antimicrobial applications, biosensor materials, 
composite fibers, cryogenic superconducting materials, cosmetic products and electronic 
components. Moreover, AgNPs have been focused on potential applications in cancer di-
agnosis and therapy [5]. Generally, the synthesis of AgNPs can be carried out using three 
different methods, including physical, chemical and biological approaches. 
The physical method prepares AgNPs by evaporation-condensation techniques us-
ing a tube furnace at atmospheric pressure. It’s a speed synthesis process based on the use 
of radiation as a reducing agent and no hazardous chemical involvement. However, low 
performance, high energy consumption, solvent contamination, and lack of uniform dis-
tribution limit its use [6]. Chemical methods use water or organic solvents in the synthesis 
of AgNPs [7,8]. They generally employ three main components, such as metal precursors, 
reducing agents, and stabilizing/protecting agents. Basically, the reduction of silver salts 
involves two stages: nucleation and growth [9]. It is characterized by its high performance. 
However, the manufactured particles lack the expected purity, having sedimentation of 
chemical products on their surfaces. Moreover, it is very difficult to prepare AgNPs with 
a well-defined size, which requires one more step to prevent particle aggregation. On the 
other hand, it’s an extremely expensive method that causes, during the synthesis process, 
the formation of too many toxic and dangerous by products [6]. 
Biological methods overcome these limitations. In fact, currently, production of na-
noparticles of defined size using different biological systems including bacteria, fungi, 
plant extracts and small biomolecules (e.g., vitamins and amino acids) is an alternative 
method for the synthesis of various nanoparticles such as gold, graphene and AgNPs [10–
12]. Green synthesis of AgNPs, based on exploiting the natural capabilities of plant sec-
ondary metabolite extract of leaves, roots, stems or, from the shell of a plant to a complete 
organism, has advantages over routine physical and chemical synthetic approaches. Its 
one-step experimental setup to reduce and stabilize bulk silver in AgNPs, biocompatible 
nature, therapeutic importance and low cost make it a very attractive tool worthy of being 
exploited [13]. 
In this context, Soursop (Annona muricata), is a plant well known for its anticancer 
activity [14]. This plant is a species of the genus Annona, of the family Annonaceae, order 
Magnoliales and division Magnoliophyta [15]. This tree tends to bloom and bear fruit most 
of the year. It is distributed in the tropical regions of Central and South America, West 
Africa and Southeast Asia [16], the A. muricata fruit is an edible collective ovoid berry, 
dark green in colour [17]. The active compounds of A. muricata are acetogenins and poly-
phenols, among others [18,19], and can be used as reducing agents for the biosynthesis of 
nanoparticles [20]. It should be noted that the anticancer activity is directly attributed to 
acetogenins, specifically the lactone functional group. Lactones are an organic compound 
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of the cyclic ester type. This functional group is responsible for blocking the complex I at 
the mitochondrial level in cancer cells, creating the accumulation of protons through the 
mitochondrial membrane, stopping production of ATP and, therefore, forcing selective 
apoptosis [21]. 
At present, several studies have demonstrated the antitumor properties of A. muri-
cata, focusing above all on its leaves as it has been traditionally considered “the cancer 
killer” in conventional medicine [22–24]. Taking into account that acetogenins predomi-
nate in leaves (LE) and peel (PE) of fruit of A. muricata, we used their extracts to synthesize 
AgNPs-LE and AgNPs-PE to explore and compare their effectiveness and selectivity 
against different types of tumors. 
2. Materials and Methods 
2.1. Collection and Conservation of Leaves and Peel of A. muricata 
The leaves and fruits of A. muricata were collected in the state of Morelos, in the 
municipality of Xochitepec (18°46′52″ N, 99°12′02″ W), at the beginning of March, being 
the month in which the botanical maturity of the fruit is reached. The leaves and fruits of 
A. muricata were characterized in the Herbarium of the Faculty of Sciences, in the 
UAEMex, State of Mexico, Mexico. Regarding the fruit, it is separated from the peel. Then 
the leaves and peel of fruit were washed three times with distilled water to remove 
impurities, and allowed to air dry at room temperature (20 °C) for 15 days. 
2.2. Biosynthesis of Silver Nanoparticles with Extracts of A. muricata 
2.2.1. Preparation of Aqueous Leaf Extract (LE) and Fruit Peel (PE) from A. muricata 
The leaves and the peel of the fruits were crushed in a mortar until obtaining a ho-
mogeneous powder with a size (grain) of 2–3 mm. The extract solutions were prepared by 
boiling 1 g of the dry fruit peel in a 100 mL Erlenmeyer flask of distilled water for ten 
minutes at 100 °C. The extract was filtered using filter paper (Whatman No. 1) [25]. A 
second filtration was carried out with tubes of 30 k Amicon Ultra-15 Centrifugal filter 
devices, at 300 rpm for 10 min. Then, crude extract was obtained via the concentration of 
extract with the use of reduced pressure. The same process was used to prepare the leaf 
extract. This extract can be stored at 4 °C for later use. 
2.2.2. Synthesis of Silver Nanoparticles 
An experimental analysis was carried out, where different tests were performed var-
ying the volume proportions of extracts and silver nitrate (1 × 10−2 M) Sigma-Aldrich, ACS 
reagent, ≥99.0%, which were 1:2, 1:1 and 2:1; The best concentration was determined by 
UV-Vis and it was found that, in both cases, the best concentrations were 1:1, consecu-
tively. Subsequently, tubes of 30 k Amicon Ultra-15 Centrifugal filter devices were fil-
tered, at 300 rpm for 10 min, to achieve purification of the generated nanoparticles. The 
synthesis was carried out as described below. The extract was used for reduction of Ag+ 
ions to Ag0, where 5 mL of shell extract and leaves were separately added to 5 mL of 
aqueous solution of silver nitrate at a concentration of 1 mM. The same process was per-
formed to prepare the silver nanoparticles using leaf extract. Silver ions were reduced to 
metallic silver in 6 h. 
2.3. Characterization 
2.3.1. Characterization of Optical Properties of AgNPs 
The optical properties of the AgNPs were determined using UV-Vis spectroscopy, 
with the Varian Cary 5000 double-beam equipment, diluting of the silver nanoparticles in 
deionized H2O until the equipment cell was filled. It was analyzed in a range of 200 to 800 
nm, in absorption mode. 
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2.3.2. Morphological and Structural Characterization of AgNPs 
The structural properties of the formed nanostructures were characterized, such as 
morphology, particle size and distribution thereof; for this a JEOL-2100 200 kV Transmis-
sion Electron Microscope (TEM) was used with filament of LaB6. Placing a drop of the 
AgNPs sample on a rack until dry, it was subsequently introduced to the sample holder 
and assembled in the equipment. 
Likewise, a Scanning Electron Microscope (SEM) was used to do a chemical mapping 
of the main elements present, in addition to performing an EDS analysis to determine and 
identify them. 
2.3.3. Characterization of the Main Functional Groups Present in the Extracts of Annona 
muricata and AgNPs 
With the help of the FTIR technique and the Bruker TENSOR 27 model equipment, 
the main functional groups that are present in the extract were recognized, in addition to 
justifying the presence of AgNPs. It was achieved by placing a drop on the analysis device 
and operating in transmittance mode from 600 to 4000 cm−1. 
2.3.4. Characterization of the Zeta Potential 
The hydrodynamic mean diameter of the NC was determined by photon correlation 
spectroscopy (PCS), using a 4700 C light-scattering device (Malvern Instruments, London, 
UK) and working with a He-Ne laser (10 mW). The light scattered by the samples was 
detected at 173°, and the temperature was set at 25 °C. The diffusion coefficient measured 
by dynamic light scattering can be used to calculate the size of the AgNPs-LE and AgNPs-
PE by means of the Stokes–Einstein equation. The homogeneity of the size distribution is 
expressed as polydispersity index (PDI), which was calculated from the analysis of the 
intensity autocorrelation function. Electrophoretic mobility (μe) and Z potential was meas-
ured after diluting a small volume of the (AgNPs-LE and AgNPs-PE) stock (with a total 
surface equal to 0.05 m2) in 1 mL of the desired buffered solution. It should be noted that 
all the buffers used in the μe studies had identical ionic strengths, being equal to 0.002 M. 
The μe measurements were made in triplicate using a nano zeta dynamic light-scattering 
analyzer (Zeta-Sizer Nano Z, Malvern Instruments, UK). 
2.4. Cell Viability Assay 
2.4.1. Cell Lines and Cytotoxicity Assays 
Breast cancer (MCF-7, MDA-MB-468), colon cancer (HCT-116), Melanoma (A-375) 
and macrophage cell lines come from the Biobank (Sistema Sanitario Publico Andaluz, 
Granada, Spain). Cells were grown in Dulbecco’s Modified Eagle’s Medium (DMEM) 
(Sigma, St. Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS) and 1% 
penicillin/streptomycin (P/S) (Sigma, St. Louis, MO, USA). The cells (5 × 103 cells) were 
incubated in 96-well plates at 37 °C in a 5% CO2 atmosphere and were treated with differ-
ent concentrations of biosynthesized nanoparticles AgNPs-PE and AgNPs-LE (100, 50, 25, 
12.5, 6.25, 3125, 1556 μg/mL) and different concentrations of extracts PE and LE (2000, 
1750, 1500, 1250, 1000, 750, 500, 250 μg for 3 days. Then, the medium was removed and 
100 μL of 3-(4,5-dimethyl-2-thiazolyl)-2, 5-diphenyl-2-tetrazoyl bromide (MTT) (at a con-
centration of 0.2 mg/mL) was added to each well and incubated for three hours. Subse-
quently, the MTT reagent was removed, and the formazan crystals formed were dissolved 
in 100 μL of dimethyl sulfoxide (DMSO) and analyzed at 570 nm in a multi-well ELISA 
plate reader. The inhibitory concentration 50 (IC50) was calculated with the GraphPad 
Prism program (GraphPad 6 Software San Diego, CA, EE. UU). All of the experiments 
were plated in triplicate and were carried out at least twice. In addition, non-treated cells 
were used as controls. 
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2.4.2. Morphological Findings 
Morphological findings were assessed using SEM. The cells were grown on sterile 
coverslips, induced for 6 days with the IC50 concentration of the extracts (PE and LE) and 
nanoparticles (AgNPs-PE and AgNPs-LE), and treated as described by Cáceres et al., 2019 
[26]. A Hitachi S-800 scanning electron microscope (Hitachi, Tokyo, Japan) was used for 
observations. Counting the number of pores per cell was performed using ImageJ with 
quantification for each cell type from 8 random photos from three independent sample 
preparations. 
2.4.3. Statistical Analysis 
The collection of the data from the different biological studies represents the mean ± 
standard deviation. Two-tailed Student t-test was used to compare differences between 
two groups. A two-tailed p-values < 0.05 was considered statistically significant. 
3. Results and Discussion 
3.1. Synthesis of Silver Nanoparticles (AgNPs) 
In the context of the generation of nanoparticles and as part of a bottom-up method, 
different variables for the formation of AgNPs must be recognized such as: temperature, 
reaction time, concentration of extracts and precursors of metal ions such as AgNO3, etc. 
Therefore, it was determined to perform a green synthesis, which guarantees in many 
ways the generation of nanoparticles using more bioavailable reducers. Likewise, the syn-
thesis was carried out at room temperature, in addition to using a very low concentration 
of the precursor salt, which implies low costs, simplicity and a lower environmental im-
pact. On the other hand, Ramachandran et al. have identified some plant metabolites such 
as ascorbic acid, citric acid, cyclic peptide, ellagic acid, gallic acid, retinoic acid and sorbic 
acid; these have been identified as compounds responsible for the reduction and stabili-
zation in the synthesis of AgNPs, in addition to providing specific properties with anti-
bacterial, anticancer and antioxidant effects [27]. 
It is important to recognize the characteristic color change of AgNPs, as shown in 
Figure 1, where leaves and fruit peel extracts undergo a color change as silver ions are 
reduced, in this case, a yellowish color (the shell extract being a little more amber than the 
leaf extract) to an intense brown. The majority of authors described a yellowish color on 
the part of the extracts that, when reacting with AgNO3, change specifically from coffee 
to amber coffee. Santhosh et al. have managed to synthesize AgNPs from leaf extracts of 
A. muricata and describe the reduction of Ag ions by changing the color of the aqueous 
extract from a yellowish to brown color, in a given time [28]. 
3.2. Spectroscopic Characterization 
3.2.1. Spectroscopic Characterization (UV-Vis) 
AgNPs offer an optical response known as surface plasmonic resonance (SPR). In 
addition, the size distribution and shape of AgNPs can be inferred through the amplitude 
of the band and the position of the maximum absorption band [29]. Based on this ra-
tionale, we selected colloidal solutions that had the best volume–volume ratio, both 
AgNO3, as well as extracts. Likewise, the reaction was monitored until observing the max-
imum absorption band with respect to time, which led to the identification of a six-hour 
nanoparticle formation period in both cases as shown in Figure 1; after this period of time 
the behavior is the same because it is the period when the nucleation and growth process 
of the AgNPs obtained ends. In the case of AgNPs-LE (Figure 1a), the maximum band 
absorption rate was recorded at 447 nm, while AgNPs-PE (Figure 1b) have a maximum 
absorption band at 448 nm. Silver nanoparticles usually record a maximum absorption 
band (RPS) that can appear from 370 nm [30] and up to 500 nm. Some authors, such as 
Mallirkajuna et al., obtained AgNPs from natural extracts such as Ocimum sanctum, regis-
tering a maximum absorption band (SPR) at 436 nm [31]; on the other hand, Kumar et al. 
Nanomaterials 2021, 11, 1273 6 of 18 
 
 
synthesized AgNPs from Annona squamosa shell extracts and reported a band (RPS) at 422 
nm [32]; likewise, Vivek et al. obtained AgNPs using Annona squamosa leaf extracts report-
ing a band (RPS) at 444 nm [33]. 
 
         
Figure 1. AgNPs-PE and AgNPs-LE characterization: UV-Vis spectra of AgNPs-PE (a) and 
AgNPs-LE (b) at different reaction times. FTIR spectrum (c) of leaf extracts (LE) and fruit peel ex-
tract (PE) of A. muricata. 
In addition, it can be seen how the absorbance increases as the reaction time elapses; 
this is because more AgNPs are generated, and reflects the disappearance of ionic Ag. 
There are notable differences between AgNPs-PE and AgNPs-LE the absorption band of 
AgNPs-PE is wider than AgNPs-LE. However, the absorbance is lower in AgNPs-LE, due 
to the size distribution found in both colloidal solutions. The results agree with what is 
established in the literature [32,33]: a quasi-spherical morphology and nanoparticles with 
sizes smaller than 50 nm can be expected in both cases, due to the position of the maxi-
mum position band after the 6 h of reaction; likewise, the same maximum absorption band 
has been observed for three consecutive months. The aqueous Annona muricata extracts 
used have an immense amount of metabolites like polyphenols, acetogenins, citric acid, 
etc. [13], some of which have already been reported as stabilizers of AgNPs in some other 
articles [34,35]. Jadhav and collaborators (2016) describe it as a layer that is responsible for 
stabilization, avoiding agglomeration and precipitation [36]. 
3.2.2. Spectroscopic Characterization (FTIR) and Z Potential 
The FTIR spectrum, shown in Figure 1c, shows a characteristic absorption band at 
1744 cm−1 (PE) and 1739 cm−1 (LE) characteristic of the vibrational mode of conjugated 
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group C=O (stretching), suggesting the presence of a γ-lactone-α, β-unsaturated that dis-
tinguishes the vast majority of acetogenins [37,38]. Likewise, the vibrational mode corre-
sponding to the groups C=C (stretching) in 1619 cm−1 (PE) and 1643 cm−1 (LE) and C-O 
(stretching) in 1373 cm−1 (PE) were recognized and 1339 cm−1 (LE), characteristic of the 
acetogenin molecule. 
By the nature of the synthesis of the AgNPs, the AgNPs were expected to be sur-
rounded by the extracts. This was confirmed by the μe and Z potential with values of−3.2 
μmcm/Vs and −34.4 mV, respectively, for AgNPs-PE, while the same parameters for 
AgNPs-LE was 1.3 μmcm/Vs and 23.3 mV, respectively. This effectively means that the 
nanoparticles could be surrounded by molecules such as acetogenins, among other me-
tabolites, which help to maintain the stability of nanoparticles in aqueous solution [39]. 
3.3. Morphological and Structural Characterization 
3.3.1. Elemental Analysis (SEM-EDS) 
An SEM/EDS analysis was carried out to corroborate the presence of the silver ele-
ment in the AgNPs (LE and PE) obtained from leaf extracts and peel of A. muricata, then 
a comparison of the analysis graphs shows elementary chemical mapping of micrographs 
and cross-line scanning ( Figure 2;  Figure 3). 
 
Figure 2. EDS analysis: comparison of the graphs of elementary analysis and cross-line scanning of 
the generated nanoparticles AgNPs-PE (a) and AgNPs-LE (b). 




Figure 3. Chemical mapping of the elements carbon (blue color), silver (yellow color) and oxygen 
(purple color), (a) AgNPs-PE and (b) AgNPs-LE. 
Regarding the micrographs, different agglomerates (clearer and brighter clusters) of 
nanoparticles can be observed in both images (Figure 2a,b). In the analysis by energy dis-
persion spectroscopy (EDS), it was possible to confirm the presence of the silver element 
in the sample, as can be seen in the spectrum of the same figures, while in the composition 
table, it is indicated that the percentage of silver is significant in both micrographs, both 
for AgNPs-PE and for AgNPs-LE; this is due to the concentration of AgNO3 from which 
the AgNPs were generated. In the same way, the EDS spectrum of the transverse line scan 
is shown in both; however, a greater intensity is reflected in the spectrum of AgNPs-PE 
(Figure 2). This could be due to the amount of nanoparticles present in the selected ag-
glomerate. 
In the chemical mapping, the following elementary maps of both nanoparticles 
(AgNPs-PE and AgNPs-LE) were obtained. In Figure 2 we can observe that in both cases 
it is revealed that the surface of the entire sample consists of Ag, C and O, as presumably 
demonstrated in the EDS spectra. The carbon, oxygen and silver maps support the inter-
pretation of the line scan, shown in Figure 2, agreeing that there is a greater intensity of 
the silver element in the AgNPs-PE. However, it is more than evident that the greater 
presence of Ag is present in the agglomerates. Likewise, it is observed that in the areas 
where there is more presence of Ag, and less amount of C and O (Figure 3). Other authors 
demonstrate the same behavior in their samples [40,41], this could be due to the prepara-
tion of the sample, since the AgNPs agglomerate when the sample is dried. 
3.3.2. Morphological Analysis (TEM) 
Through Transmission Electron Microscopy (TEM), the size and shape of AgNPs pre-
viously synthesized with A. muricata leaves and fruit peel were elucidated. As can be seen 
in Figure 3a,b, it is evident that in both cases AgNPs with sizes smaller than 50 nm were 
obtained, fulfilling one of the main objectives of this investigation, since it offers better 
optical properties [42] and biocompatibility [43,44]. Currently, Santhosh et al., [28] have 
already synthesized AgNPs with leaf extracts of A. muricata. However, they obtained an 
average nanoparticle size of up to 103 nm, which is not favorable for the objective appli-
cation of this research; therefore, it was decided to experiment with different concentra-
tions of both the precursor salt and the extracts. Likewise, Kumar et al. synthesized AgNPs 
from fruit peel extracts of A. squamosa, thus reporting a large polydispersity ranging from 
20 to 60 nm [32], which is not viable for the application required in this project [43,44]. 
It should be noted that quasi-spherical AgNPs-PE and AgNPs-LE were obtained as 
shown in the micrographs of Figure 4a2,b1. Other authors report it as irregular spherical 
or simply spherical forms. The ions capture an electron from the bioreducer and a nucleus 
or seed is formed. These are formed in the entire solution and there is a “competition” for 
the growth of the nuclei until the formation of the nanoparticles. Due to this competition 
between them, which is governed by thermodynamic parameters, a defined size is 
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achieved and when the molecules are at this point they absorb superficially, acting as a 
protective layer to prevent the nanoparticles from continuing to grow and avoid collisions 
[27,45]. Likewise, little agglomeration is observed, which is important for the treatment in 
breast cancer cell lines, since they can be effectively dispersed in the medium. 
. 
Figure 4. Micrograph obtained by TEM of AgNPs, as well as size distribution graph and HRTEM. 
The micrographs show the nanoparticles generated from the extracts of leaves and fruit peels of 
Annona muricata. The LE-AgNPs generated show an average diameter size of 19.63 ± 3.7 nm (a1) 
and a quasi-spherical shape (a2). The inter-planar spaces with a distance of 2339 Å were deter-
mined for the AgNPs-PE which corresponds to the family of planes (111) (a3). The LE-AgNPs gen-
erated show a quasi-spherical shape, individualized AgNPs can be seen without agglomerations 
(b1). The average diameter size of 16.56 ± 4.1 nm for the AgNPs-PE (b2).The inter-planar distances 
of the AgNPs-LE were measured, obtaining a distance of 2040 Å, which corresponds to the family 
of planes (200) (b3). 
On the other hand, the measurement of the diameter of the nanoparticles observed 
in the micrographs was carried out, both of the AgNPs-PE and of the AgNPs-LE by means 
of the ImageJ software, thus obtaining an average diameter size of 19.63 ± 3.7 nm for 
AgNPs-LE (Figure 4a1) and, with a polydispersity of sizes ranging from 10 to 28 nm. Like-
wise, the average diameter size of the AgNPs-PE (Figure 4b2) was obtained, which turned 
out to be 16.56 ± 4.1 nm, observing a polydispersity of greater range that goes from 8 to 26 
nm. It is evident that the AgNPs-PE have more uniform sizes, even less polydispersity is 
shown both in histograms and in the same micrographs with respect to the AgNPs in 
addition, very little agglomeration of AgNPs is recognized in both cases, at the same time 
observing sizes smaller than 50 nm, thus corroborating the viability for the desired appli-
cation. 
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The data obtained from the DLS measurements of hydrodynamic size and polydis-
persity index (PDI) were 41.16 nm and 0.481 for AgNPs-PE, while the measurements for 
AgNPs-LE were 48.39 nm and 0.643. 
Additionally, an analysis was conducted with HRTEM, with both AgNPs-PE and 
AgNPs-LE, in order to confirm that both AgNPs were formed by Ag0. The inter-planar 
spaces with a distance of 2339 Å were determined for the AgNPs-PE (Figure 4a3), which 
corresponds to the family of planes (111); in the same way, the inter-planar distances of 
the AgNPs-LE were measured, obtaining a distance of 2040 Å, which corresponds to the 
family of planes (200) as shown in Figure 4(b3), taking as reference the JCPDS card 00-004-
0783. 
3.4. Cell Viability Test 
The percentage of cell viability of the cell lines was determined, compared to different 
concentrations of AgNPs and extracts by the assay of 3-(4,5-dimethyl-2-thiazolyl)-2, 5-di-
phenyl-2-tetrazoyl bromide (MTT) (Figure 5). We determined their inhibitory concentra-
tion (IC50) after 3 days of treatment (Table 1). 




Figure 5. Graphs of the percentage of cell viability with respect to different concentrations of LE, 
PE, AgNPs-LE and AgNPs-PE. 
Table 1. Antiproliferative activities (IC50 (μg/mL)) of AgNPs-PE, AgNPs-LE, PE in cancer cell lines 
and macrophages. All the experiments were performed in triplicate. 
Treatment 
MCF-7 MDA-MB-468 A-375 HCT-116 Macrophages 
IC50 R2 IC50 R2 IC50 R2 IC50 R2 IC50 R2 
AgNPs-PE 2.996 0.9309 1.685 0.9662 2.943 0.9728 1.285 0.9623 13.7 0.9980 
AgNPs-LE 3.109 0.9806 1.910 0.9825 8.404 0.9672 2.004 0.9986 10.7 0.9792 
PE 1278 0.9592 264.9 0.9676 1880 0.9934 309.3 0.9731 - - 
LE 2280 0.9803 776.4 0.9879 2478 0.9726 404.8 0.9708 68.97 0.9674 
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The antitumor effect of LE has been previously reported [46]. Fattahi et al. reports an 
activity of the aqueous extracts against the MCF-7 line with an IC50 of 2000 μg/mL rela-
tively similar to those that we have obtained [47]. As shown in Table 1, the IC50 values for 
the PE were lower than LE for all tumor cell lines tested. Indeed, breast cancer cells have 
been demonstrated to be more sensitive to PE than LE, reducing its IC50 by 65.88% and 
43.95% for MDA-MB-468 and MCF-7, respectively. In addition, both A-375 melanoma and 
HCT-116 colon cancer cell lines showed similar sensitivity to PE with 24.14% and 23.6% 
of IC50 decrease in comparison to LE. 
On the other hand, our results demonstrated that all cancer cell lines were drastically 
more sensitive to our biosynthesized AgNPs than extract, as they achieved a better effect 
with 99% lower concentrations. In this context, several studies demonstrated that the 
AgNPs had an important anticancer activity. AgNPs synthesized using other plants 
demonstrated the anti-proliferative activity against several cancer cell lines including hu-
man colorectal adenocarcinoma, kidney and cervix [48]. The biosynthesized AgNPs based 
on Commelina nudiflora aqueous extract showed reduced cell viability and increased cyto-
toxicity in HCT-116 colon cancer cells with IC50 concentration of 200 and 100 μg/mL, re-
spectively [49]. Saratale and collaborators prepared AgNPs using Taraxacum officinale 
showing their high cytotoxic effect against human liver cancer cells (HepG2) using an IC50 
about 60 μg/mL [50]. The Nostoc linckia based AgNPs had anticancer activity against breast 
cancer cell MCF-7 with an IC50 of 27.79 μg/mL [51]. 
To our surprise, our results showed that AgNPs-PE were more potent than AgNPs-
LE reaching 64.98%, 37%, 11.78% and 3.63% more effectiveness in HCT-116, A-375, MDA-
MB-468 and MCF-7, respectively. In addition, the IC50 obtained have been much lower 
than those described in the literature since with an IC50 of only 1.685 μg/mL, our AgNPs-
PE from A. muricata were able to induce cytotoxicity to MDA-MB-468, a triple negative 
breast cancer cell line (do not express estrogen receptor (ER), progesterone receptor (PR), 
and do not have HER-2/Neu amplification), characterized by a poor outcome compared 
to the other subtypes of breast cancer [52]. To the best of our knowledge, the only study 
that analyzes the antitumor effect of AgNPs-PE from A. muricata was in an AMJ-13 breast 
cancer cell line (ER−,PR− and HER2/neu+) and reported an IC50 of 17.34 μg/mL using 
AgNPs synthetized from A. muricata stock solution 10-fold more concentrated than ours 
[53]. This could be due to the geographical origin of the plant, the season in which both 
the leaves and the peel of the fruit were collected and even its age [54–56]. There are spe-
cific investigations of the Annona muricata species, where significant variations in the bio-
chemical composition are reflected depending on the collection season [57]. 
A comparison between the tumor cell lines (MCF-7, MDA-MB-468, HCT-116 and A-
375) and the macrophage cell line was established in order to define the selective activity 
of the AgNPs and extract through the determination of the in vitro therapeutic index (TI) 
(Table 2). The ratio of the toxic dose to the therapeutic dose (In vitro TI = IC50 non-tumor 
cell line/IC50 tumor cell line) is defined as the in-vitro TI of a drug [58]. In macrophages 
we found that the cytotoxic effect of LE extracts was remarkably higher. In fact, our results 
showed that LE treatment is more cytotoxic for macrophages than for cancer cells. This 
could be due to alterations in the cytoskeletal function as a result of the treatment with LE 
and possibly due to the specific function of macrophages. Here the importance of treat-
ment with PE stands out, since at high concentrations there are no indications that it is 
cytotoxic against macrophages [59]. This could be due to the phytochemicals difference 
existing between the LE and PE extracts such as phenolic compounds [39], which have 
reported apoptosis in macrophages [40]. 
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Table 2. Therapeutic indexes (μg/mL) for AgNPs-PE, AgNPs-LE, PE and LE in different tumor cell 
lines compared to the macrophage cell line. * ND (not determined). 
Treatment MCF-7 MDA-MB-468 A375 HCT-116 
AgNPS-PE 4.34 8.13 4.655 10.66 
AgNPS-LE 3.44 5.602 1.273 5.245 
PE ND * ND * ND * ND * 
LE 0.030 0.088 0.027 0.170 
Furthermore, TI was better by far for almost all cell lines treated by AgNPs-PE (Table 
2). The best TI was achieved by HCT-116 and MDA-MB-468 (TIs = 10.66 and 8.13 respec-
tively). It should be noted that macrophages are cells of the immune system that are found 
in tissues and serve as protection against external agents. Our results suggest that macro-
phages are less susceptible to damage from acetogenins, and it could be that their effect is 
directly on cancer cells. This is due to the rapid proliferation of cancer cells, since they 
require high levels of energy, so they may be more sensitive to their decline and have 
important physiological changes [60]. Some authors attribute the effect of aqueous ex-
tracts to the release of NO and TNF-α, which is capable of upregulating the expression of 
iNOS and TNF-α through the transactivation of NF-κB, and this may be a mechanism by 
the which this herbal medicine causes its therapeutic effects [61]. The mechanism of action 
of the acetogenins in cancer cells has been reported in terms of apoptotic cell death and 
control of the cell cycle checkpoint [62]. Other authors suggest that the presence of AgNPs 
induces the formation of reactive oxygen species, which are considered the main source 
of DNA damage [63,64]; it could be then inferred that both acetogenins and AgNPs target 
cells with the greatest energy need, such as cancer cells, which justifies our results. 
After the determination of the anti-tumor activity of the different treatments against 
the tumor cell lines, we selected MDA-MB-468 and MCF-7 lines, in order to analyze its 
proliferation and morphological changes after 6 days of induction of different compounds 
and determine if the use of IC50 will achieve total cell death. Our results demonstrated that 
unlike cells treated with high doses of extracts, lower doses of the AgNPs caused total cell 
death (Figure 6). 
In fact, using SEM we observed that both MCF-7 and MDA-MB-468 control cells were 
abundant, highly adherent to the substrate and its surface covered by multiple microvil-
lous extensions. However, treatment of MCF-7 and MDA-MB-468 cells with 2280 μg/mL 
and 776.4 μg/mL of the LE extract, respectively, results in a slight effect on the prolifera-
tion of the cell lines- a little more marked in the MDA-MB-468 cells. Even better, the treat-
ment with 1278 μg/mL and 264.9 μg/mL of PE extract has achieved clear cell death with a 
concomitant decrease in cell density in both MCF-7 and MDA-MB-468 cell lines, respec-
tively. This death has been further accentuated with the use of 2.996 μg/mL and 3.109 
μg/mL of AgNPs-LE treatment in both cell lines. Moreover, a similar effect has been ob-
served with the use of even smaller amounts of AgNPs-PE (1.685 μg/mL and 1.910 
μg/mL). The treatment with PE, AgNPs-LE and AgNPs-PE showed that only a few round 
cells remained anchored to the substrate, showing in most of the cases disrupted cytoplas-
mic membranes and multiple “pores” with different sizes (yellow arrows, Figure 6f). 
Moreover, cells presented a “flat surface” due to the loss of microvilli and filopodia struc-
tures and the apparition of apoptotic bodies a clear signal of death by apoptosis (Figure 
6). These results are in concordance with those reported by Jabir and collaborators in THP-
1 and AMJ-13 cell lines [53]. 




Figure 6. Microscopy micrographs of MCF-7 and MDA-MB-468 cells after 6 days of IC50 treatments 
with different compounds. Cell controls are shown in (A,a,B,b) under treatment with LE extract 
(C,c,D,d) showed cells with epithelial form strongly adhered to the surface of the culture co-
verslip, and PE show cells with loss of microvilli (E,e,F), in addition to multiple pores (arrows yel-
low) (f), the micrographs of the cells treated with AgNPs-LE show a decrease in cells compared to 
the controls (G,H). Cells treated with NPs also showed pore formation (yellow arrows, g,h) and a 
flatter cell surface than controls, due to the loss of microvilli and filopod structures. Cells treated 
with AgNPs-PE (I,J) also show cell decrease, in addition to giant cells with destructured cytoplas-
mic membrane (red arrows, i,j) Scale bar (200–10 μm). 
Moutin et al. [65] attribute the morphological deteriorations in cells exposed to 
AgNPs to actin interference with the structure and functions of the cytoskeleton. Damage 
to the cytoskeleton could result from calcium fluctuations and genetic dysregulation; this 
creates coherence, since the +ions that are released from the nanoparticles are involved in 
cell signaling cascades with the activation of Ca2+ release that further activates catabolic 
enzymes and damages mitochondrial membranes. Furthermore, the repeated entry and 
exit of calcium into the mitochondria could result in damage to the mitochondrial mem-
brane, resulting in the production of ROS and inhibition of ATP synthesis [66]. Knowing 
the effects that the AgNPs and the acetogenins contained in the extracts have on the breast 
cancer cell lines, it is easy to adjudge that the cytotoxic effect will be potentiated when the 
nanoparticles are formed with the extracts, since they will have a duplex function. Like-
wise, it must be recognized that the cytotoxic effect of the AgNPs will be greater than the 
extracts due to the concentrations used for their generation. 
The reactive oxygen species (ROS) at the cellular level are responsible for inducing 
DNA damage and, therefore, leading to cell death. Some authors report studies where 
biosynthesized AgNPs from natural extracts, through redox reactions, where the reducing 
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agent is usually a set of polyphenols present in the extracts, whose function is to cause 
oxidative stress, which leads to cell death through the mitochondria [67]. Likewise, it is 
known that the possible mechanism involved in cellular toxicity induced by AgNPs, trig-
gers reactive oxygen species (ROS) by inhibiting the synthesis of intracellular antioxidants 
[63]. 
4. Conclusions 
In this manuscript we demonstrate, for the first time, that even though the leaf of the 
Annona muricata has been traditionally considered “the cancer killer” in conventional 
medicine, the peel extract of this fruit has an even more powerful antitumor effect. In fact, 
we were able to produce nanoparticles, with a potent in-vitro antitumor effect, from con-
centrations of leaves (LE) and peel (PE) of fruit of A. muricata extracts much lower than 
those reported by other authors. Moreover, this difference is accentuated with AgNPs 
where the destruction of cancer cells was achieved using concentrations that do not exceed 
3 μg/mL with a better therapeutic index in the different tumor strains. Our results are very 
promising and provide the basis for the development of in-vivo experiments for their val-
idation. In conclusion, we present a low-cost one-step experimental setup to generate 
AgNPs-PE, whose biocompatibility and potent therapeutic effect make it a very attractive 
tool worthy of being exploited. 
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